A carregar...
Targeting IL‐5 pathway against airway hyperresponsiveness: A comparison between benralizumab and mepolizumab
BACKGROUND AND PURPOSE: Airway hyperresponsiveness (AHR) is a central abnormality in asthma. IL‐5 may modulate AHR in animal models of asthma, but the available data is inconsistent on the impact of targeting IL‐5 pathway against AHR. The difference between targeting IL‐5 or the IL‐5 receptor, α sub...
Na minha lista:
| Publicado no: | Br J Pharmacol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7520436/ https://ncbi.nlm.nih.gov/pubmed/32857420 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.15240 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|